The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical SynthesisFull Access

What is Supportive Psychotherapy?

Abstract

This article reviews the meaning, use, and utility of supportive psychotherapy, a widespread treatment with an undeservedly malign birthright and history. This entails sorting through the historical definitions of supportive therapy and reviewing its good research track record achieved despite being the comparison condition. The author then defines brief supportive psychotherapy (BSP), a manualized, “common factors” treatment that has fared well in research settings, which may provide a model for clinical and research use in the future.

“I don’t get no respect.” –Rodney Dangerfield (1)

What is supportive psychotherapy? The term has been widely used, poorly and variously defined, and often disparaged. It can mean anything and nothing; yet also, when carefully defined and applied, it can describe a potent treatment that (I will argue) lies at the core of all good psychotherapy. So, supportive psychotherapy deserves clinical attention. This article briefly reviews the history and meaning of “supportive psychotherapy” (SP), its clinical and research use, and then suggests a research-tested definition of SP for general usage.

Definitions

The original definition of SP was, essentially, second-rate therapy for second-rate patients. During the heyday of psychoanalysis, the goal was to treat analyzable patients with psychoanalysis. Psychotherapists then faced the problem of unanalyzable patients: those without the reflective capacity to hear interpretations, or with “pseudoneurotic schizophrenia” (2), who appeared analyzable but then unraveled on the couch. These patients ended up receiving a more bolstering, “supportive” treatment while sitting upright, in which less distant (less “neutral”) therapists shored up defenses and eschewed interpretation. This unpsychoanalysis for the unanalyzable was not the preferred mode of treatment, not for the preferred patients, and hence, from its onset, had a pejorative edge.

As supportive psychotherapy was negatively defined as not-psychoanalysis, it became an umbrella term for every form of psychotherapy other than psychoanalysis itself. All evidence-based therapies, such as cognitive-behavioral therapy (CBT) and interpersonal psychotherapy (IPT), technically fall under the rubric. Yet so stretched a denotation renders the term meaningless, particularly in the current era where few patients actually receive psychoanalysis. The Wikipedia definition: “Supportive psychotherapy is a psychotherapeutic approach that integrates psychodynamic, cognitive-behavioral, and interpersonal conceptual models and techniques” (3) is unhelpful and wrongheaded. Some clinicians, perhaps influenced by the term “supportive,” seem to view SP as handholding by social workers, i.e., being nice to patients. That description, too, seems inadequate and unfair.

Other clinicians and researchers (49) have attempted to define SP more positively and meaningfully, although this still has produced somewhat diffuse and at times contradictory definitions. The type of SP may vary with the diagnoses of a target treatment population (e.g., psychotic versus nonpsychotic) or with the theoretical orientation of its proponents. It may have underlying psychodynamic roots (shoring up adaptive defenses) or not.

Clinical Use of Supportive Psychotherapy

Surveys of clinicians have led to claims that supportive psychotherapy is the most widely used of psychotherapeutic interventions. For example, the 1998 National Survey of Psychiatric Practice found that psychiatrists treated 36% of patients with SP, 19% with insight-oriented therapy, 6% with CBT, and 1% with psychoanalysis (10). Yet what does this mean? Clinicians are not always specific in defining their interventions (many will say that they “do” CBT or IPT despite lacking relevant training), and the broad (lack of) definition of SP may have lumped diverse approaches in specious unity. Further, practice patterns may have changed considerably in the past 15 years since that survey. Nonetheless, a lot of clinicians believe they are conducting supportive psychotherapy with their patients.

My impression as a supervisor of residents and of clinicians in practice is that many therapists treat patients with what they believe is supportive psychotherapy for no particular indication, following no guideline. Rather than working from a diagnostic assessment to consideration of evidence-based treatments for a target syndrome, they fall into treating the patient “supportively”: a somewhat indeterminate approach encompassing various techniques. In this setting, supportive therapy becomes a synonym for eclectic therapy, perhaps partly bolstering the Wikipedia definition. (Such an approach does not “integrate” different techniques, however, it merely mixes them.)

Research on Supportive Psychotherapy

Supportive psychotherapy has rarely been studied as the primary treatment for anything (11). It has instead provided the foil to fancier treatments, appearing in numerous studies as a comparator or control. Supportive therapists in research trials have rarely been handpicked: they have often been less allegiant and less convinced of its efficacy than of the opposing condition (12). Douglas asserted, “supportive therapy has not been sufficiently well defined in a manual or tested in controlled clinical trials to be considered evidence based” (9, p. 450). Yet given its lack of researcher allegiance (13, 14) and likely therapist allegiance (12), factors that have been shown to influence study outcome, supportive psychotherapy has fared remarkably well. Too often, researchers favoring another brand name of psychotherapy have been frustrated by a “dead heat” outcome, in which SP has done just as well as the touted experimental treatment.

To cite just a few of many possible examples: a randomized study comparing Kernberg’s Transference-Focused Psychotherapy, Linehan’s Dialectical Behavioral Therapy, and supportive psychotherapy for 90 patients with borderline personality disorder found no clear differential outcome among treatments (15). A large trial (N=491) comparing highly favored Cognitive Behavioral Analysis System of Psychotherapy (CBASP), a therapy specifically designed to treat chronic depression, to supportive psychotherapy as adjuncts to a pharmacotherapy algorithm for treatment resistant, chronically depressed patients showed no difference between treatments (16). (Neither type of psychotherapy produced better results than pharmacotherapy alone.) In a 16-week study of 94 dysthymic patients, SP equaled IPT in treatment effect (17). For depressed HIV-positive patients, SP matched CBT in benefit despite having fewer treatment sessions (18). Supportive psychotherapy worked as well as brief dynamic psychotherapy in a study of Cluster C personality disorders (19).

Such findings suggest that SP is active, efficacious, and often achieves lasting, meaningful results (11). In comparison to more grueling exposure-based treatments for anxiety disorders, such as posttraumatic stress disorder (PTSD), SP has had a lower dropout rate (20). Indeed, its potency led Hellerstein and colleagues to declare “supportive therapy as the treatment model of choice” for many patients (21). A recent meta-analysis of 31 randomized trials supports this assertion. Cuijpers et al. (22) found nondirective supportive therapy (NDST) effective in treating depression in adults, with no differences relative to other psychotherapies after controlling for researcher allegiance. The meta-analysts concluded that NDST “has a considerable effect on symptoms of depression” (22).

Similarly, Wampold has shown the difficulty in finding differences between any two credible, reasonably well delivered psychotherapies matched for time and therapist experience (23). Supportive psychotherapy has impressed me over the years as a worthy treatment. A treatment study that shows a rival treatment surpassing supportive therapy passes a much tougher test than one compared with a waiting list condition. Supportive psychotherapy works.

How and Why Does it Work?

In the course of a research career involving psychotherapy outcome studies, I have considerable experience with supportive psychotherapy. Dr. Michael Sacks and I have co-written an unpublished manual of supportive psychotherapy that several researchers have used in multiple outcome studies. This defined, time-limited form of brief supportive psychotherapy (BSP) has fared well in treatment trials––again, sometimes better than the investigators allegiant to other therapies might have wished (1618, 24, 25).

This version of brief supportive psychotherapy consists of an affect-focused, “common factors” approach to treatment. Its roots derive from the Client-Centered Therapy of Carl Rogers (4). The common factors, outlined by master psychotherapists like Jerome Frank (5, 6), earned that term because such factors are believed common and crucial to all psychotherapies (see Table 1). Most “common factors” appear good therapeutic common sense. Nondirective, except in the therapist’s pursuit of the patient’s affect, BSP allows the patient to set the course of treatment. Like Rogers, the therapist listens carefully and reflects back affect to the patient with careful clarifications. This builds the therapeutic alliance, which correlates with treatment outcome (e.g., 23, 26). BSP helps many patients to develop a new vocabulary for their emotions, recognizing that “upset” can variously mean sad, anxious, or angry. This kind of therapy may sound easy, but it is hard to do well, particularly when a negative affect emerges that may make both the therapist and patient uncomfortable (27). Yet gaining comfort with one’s emotions adds a dimension to life and a new understanding of one’s world. To quote Frank: “[T]he task of the therapist––whatever his or her technique––is to clarify symptoms and problems, inspire hope, facilitate experiences of success or mastery, and stir the patient’s emotions. …[T]he main effect of such activity is to alleviate the patients’ sense of powerlessness to change themselves or their environment, a condition that may be termed demoralization” (6, pp. xiii–xiv).

Table 1. “Common Factors” of Psychotherapya
Affective arousal (response)
Feeling understood by therapist (relationship)
Framework for understanding (rationale)
Expertise (rigor)
Therapeutic procedure (ritual)
Optimism for improvement (realism)
Success experiences (remoralization)

a Based on Frank and Frank (6).

Table 1. “Common Factors” of Psychotherapya
Enlarge table

Unlike many other evidence-based therapies, BSP offers the patient no overarching explanation for his or her disorder or why the treatment will work. The therapist may underscore the importance of understanding one’s emotions. It assigns no homework, conferring the advantage that the patient cannot fail to do the homework and end up feeling like a bad patient. We have included a little psychoeducation about the target disorder, but there is no attempt to weigh the evidence of cognitions, role-play interpersonal scenarios, or to get the patient to “do” anything more than reflect on his or her emotions. In some respects, then, BSP is an elemental, pure therapy, psychotherapy stripped down to its basics.

Table 2 provides a listing of “do’s and don’ts” for BSP. It should clarify that BSP is the inverse of the Wikipedia definition: the core of psychotherapy without the bells and whistles of psychodynamic, IPT, or CBT therapies. Our research has shown that therapists can adhere to BSP (28). Table 3 lists some of the adherence items that help to define good BSP therapy. Wampold (23) and others have shown that such “common factors” account for about half of the total variance of psychotherapy outcome, whereas the added interventions that define CBT, IPT, DBT, and the rest account for only another 10%−15%. Cuijpers et al. (22) in their meta-analysis found that “most of the effect of therapy for adult depression is realized by non-specific factors, and our results suggest that the contribution of specific effects is limited at best.”

Table 2. Do’s and Dont’s of Brief Supportive Psychotherapy
DODON’T
Make an emotional connection
Problem solve for the patient
Follow affect
Structure the session
Let it linger
Be too active
Encourage catharsis
Interrupt the patient’s feelings
Build the alliance
Interpret transference
Emphasize patient’s strengths (but not to avoid negative affect)
Assign homework

Give up (or the patient will too)
Table 2. Do’s and Dont’s of Brief Supportive Psychotherapy
Enlarge table
Table 3. Brief Supportive Psychotherapy Adherence Items
1. When interpersonal issues were raised, the therapist facilitated the discussion but did not provide any theoretical framework.
2. The therapist conveyed the sense that he/she was a nonjudgmental helper, who had no circumscribed agenda, but would support whatever discussion the patient initiated.
3. [Rogerian echoing/feedback] The therapist echoed the patient’s concerns as a means of facilitating the patient’s discussion of those concerns.
4. The therapist offered supportive encouragement without a theoretical framework (e.g., “You have control over your depression”).
5. The therapist made connections with themes or topics that had been important to the client in a previous session.
6. Avoidance of specific techniques (e.g., “situational analysis” in CBASP).
Table 3. Brief Supportive Psychotherapy Adherence Items
Enlarge table

These common factors help build a treatment alliance necessary for effective pharmacotherapy as well (29). Thus, in training BSP therapists, I have offered them a paradoxical therapeutic challenge:

First: if you cannot do this, the rest of psychotherapy does not matter. Delivering the common factors well is the sine qua non of all treatment. You will not be able to deliver the specific techniques of CBT or the pills of pharmacotherapy if you cannot make a strong alliance.

Second: if you can do this, the rest of psychotherapy does not matter. The bulk of what you can provide, you are already providing.

Therapists trained in this BSP approach who come from other schools of psychotherapy, such as CBT, may initially feel de-skilled, stripped of their usual interventions, forced to listen more, and to let the patient lead. Some previously thought they knew supportive therapy until they came to it. In our trials, many therapists came to appreciate the approach, and some converted to a supportive therapy stance in their outside practices (30).

Patients entering the multisite research evaluating the value of augmenting medication with psychotherapy (REVAMP) study of chronic treatment-resistant depression (16) probably were not seeking BSP. They either wanted the medication algorithm that all patients received, or else the depression-focused CBASP treatment. BSP was the obvious control condition. Many patients had never received psychotherapy before, were unsure what to make of it, and initially reluctant to try it. Yet many ultimately felt liberated by the chance to talk about their feelings and lives in a new way, and even patients who did not ultimately respond on depression scales appreciated the treatment (30).

Discussion

Supportive therapy has thus been the Rodney Dangerfield of psychotherapies: from the beginning, it has gotten no respect. It deserves respect, however, as the basis of all psychotherapy, and as a potent treatment in its own right. Some residency training programs tacitly recognize the core psychotherapeutic aspects of supportive therapy in employing a “Y model” of psychotherapies in which SP represents the common stem of all available treatments (31). Supportive psychotherapy deserves research trials in which it is the “treatment model of choice” (21) rather than a neglected alternative. Clinicians should consider using supportive psychotherapy as a defined entity rather than an eclectic jumble, and doing so proudly.

Address correspondence to: John C. Markowitz, M.D., New York State Psychiatric Institute, 1051 Riverside Dr., Unit #129, New York, NY 10032; e-mail:

Author Information and Disclosure

John C. Markowitz, M.D., Professor of Clinical Psychiatry, Columbia University College of Physicians & Surgeons; Research Psychiatrist, New York State Psychiatric Institute New York, NY

The author reports no competing interests.

Dr. Markowitz was supported in part by grant MH079078 from the National Institute of Mental Health and by New York State Psychiatric Institute.

References

1 Dangerfield R: It’s Not Easy Bein’ Me: A Lifetime of No Respect But Plenty of Sex and Drugs. New York, HarperEntertainment, 2004Google Scholar

2 Hoch P, Polatin P: Pseudoneurotic forms of schizophrenia. Psychiatr Q 1949; 23:248–276CrossrefGoogle Scholar

3 http://en.wikipedia.org/wiki/Supportive_psychotherapy, accessed 5/12/13Google Scholar

4 Rogers CR: Client-centered Therapy. Boston, Houghton Mifflin, 1951Google Scholar

5 Frank JD: Eleventh Emil A. Gutheil memorial conference. Therapeutic factors in psychotherapy. Am J Psychother 1971; 25:350–361CrossrefGoogle Scholar

6 Frank JD, Frank JB: Persuasion and Healing: A Comparative Study of Psychotherapy. Baltimore, Johns Hopkins, 1993Google Scholar

7 Novalis PN, Rojcewicz SJ, Peele R: Clinical Manual of Supportive Psychotherapy. Washington, D.C., American Psychiatric Press, 1993Google Scholar

8 Pinsker H: A Primer of Supportive Psychotherapy. Hillsdale, NJ, The Analytic Press, 1997Google Scholar

9 Douglas CJ: Teaching supportive psychotherapy to psychiatric residents. Am J Psychiatry 2008; 165:445–452CrossrefGoogle Scholar

10 Tanielian TL, Marcus SC, Suarez AP, Pincus HA: Datapoints: trends in psychiatric practice, 1988–1998: II. Caseload and treatment characteristics. Psychiatr Serv 2001; 52:880CrossrefGoogle Scholar

11 Hellerstein DJ, Markowitz JC: Developing supportive psychotherapy as evidence-based treatment. (letter) Am J Psychiatry 2008; 165:1355–1356, author reply 1356CrossrefGoogle Scholar

12 Falkenström F, Markowitz JC, Jonker H, Philips B, Holmqvist R: Can psychotherapists function as their own controls? Meta-analysis of the crossed therapist design in comparative psychotherapy trials. J Clin Psychiatry 2013; 74:482–491CrossrefGoogle Scholar

13 Gaffan EA, Tsaousis I, Kemp-Wheeler SM: Researcher allegiance and meta-analysis: the case of cognitive therapy for depression. J Consult Clin Psychol 1995; 63:966–980CrossrefGoogle Scholar

14 Luborsky L, Diguer L, Seligman DA, Rosenthal R, Krause ED, Johnson S, et al.: The researcher’s own therapy allegiances: a “wild card” in comparisons of treatment efficacy. Clin Psychol (New York) 1999; 6:95–106CrossrefGoogle Scholar

15 Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF: Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry 2007; 164:922–928CrossrefGoogle Scholar

16 Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME; REVAMP Investigators: Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry 2009; 66:1178–1188CrossrefGoogle Scholar

17 Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks MH: A comparative trial of psychotherapy and pharmacotherapy for “pure” dysthymic patients. J Affect Disord 2005; 89:167–175CrossrefGoogle Scholar

18 Markowitz JC, Kocsis JH, Fishman B, Spielman LA, Jacobsberg LB, Frances AJ, Klerman GL, Perry SW: Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Archives of General Psychiatry 1998; 55:452–457CrossrefGoogle Scholar

19 Hellerstein DJ, Rosenthal RN, Pinsker H, Samstag LW, Muran JC, Winston A: A randomized prospective study comparing supportive and dynamic therapies. Outcome and alliance. J Psychother Pract Res 1998; 7:261–271Google Scholar

20 Hembree EA, Foa EB, Dorfan NM, Street GP, Kowalski J, Tu X: Do patients drop out prematurely from exposure therapy for PTSD? J Trauma Stress 2003; 16:555–562CrossrefGoogle Scholar

21 Hellerstein DJ, Pinsker H, Rosenthal RN, Klee S: Supportive therapy as the treatment model of choice. J Psychother Pract Res 1994; 3:300–306Google Scholar

22 Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G: The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 2012; 32:280–291CrossrefGoogle Scholar

23 Wampold BE: The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ, Lawrence Erlbaum Associates, 2001Google Scholar

24 Markowitz JC, Kocsis JH, Christos P, Bleiberg K, Carlin A: Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. J Nerv Ment Dis 2008; 196:468–474CrossrefGoogle Scholar

25 Schramm E, Hautzinger M, Zobel I, Kriston L, Berger M, Härter M: Comparative efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early onset chronic depression: design and rationale of a multisite randomized controlled trial. BMC Psychiatry 2011; 11:134CrossrefGoogle Scholar

26 Crits-Christoph P, Gibbons MB, Hamilton J, Ring-Kurtz S, Gallop R: The dependability of alliance assessments: the alliance-outcome correlation is larger than you might think. J Consult Clin Psychol 2011; 79:267–278CrossrefGoogle Scholar

27 Markowitz JC, Milrod BL: The importance of responding to negative affect in psychotherapies. Am J Psychiatry 2011; 168:124–128CrossrefGoogle Scholar

28 Markowitz JC, Spielman LA, Scarvalone PA, Perry SW: Psychotherapy adherence of therapists treating HIV-positive patients with depressive symptoms. J Psychother Pract Res 2000; 9:75–80Google Scholar

29 Krupnick JL, Sotsky SM, Simmens S, Moyer J, Elkin I, Watkins J, Pilkonis PA: The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1996; 64:532–539CrossrefGoogle Scholar

30 Markowitz JC, Manber R, Rosen P: Therapists’ responses to training in brief supportive psychotherapy. Am J Psychother 2008; 62:67–81CrossrefGoogle Scholar

31 Plakun EM, Sudak DM, Goldberg D: The Y model: an integrated, evidence-based approach to teaching psychotherapy competencies. J Psychiatr Pract 2009; 15:5–11CrossrefGoogle Scholar